(Q84526014)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20603238%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

title

High IL-12 p35 and IL-23 p19 mRNA expression is associated with superior outcome in ovarian cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20603238%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20603238%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author name string

Anna Maria Wolf

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20603238%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Daniel Reimer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20603238%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Christian Marth

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20603238%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Alain G Zeimet

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20603238%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Dominik Wolf

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20603238%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

publication date

17 June 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20603238%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20603238%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20603238%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20603238%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

244-250

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20603238%20AND%20SRC:MED&resulttype=core&format=json

Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation

7 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.024

Producer cells of interleukin-12

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.024

Interleukin-12: biological properties and clinical application

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.024

Phase I study of the sequential combination of interleukin-12 and interferon alfa-2b in advanced cancer: evidence for modulation of interferon signaling pathways by interleukin-12.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.024

Effects of interleukin-12 on the immune response to a multipeptide vaccine for resected metastatic melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.024

IL-23 promotes tumour incidence and growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.024

Antitumor and antimetastatic activity of IL-23

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.024

Immunological and antitumor effects of IL-23 as a cancer vaccine adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.024

The secreted form of the p40 subunit of interleukin (IL)-12 inhibits IL-23 functions and abrogates IL-23-mediated antitumour effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.024

Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.024

Interleukin-12 and the regulation of innate resistance and adaptive immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.024

Overexpression of interleukin-12 enables dendritic cells to activate NK cells and confer systemic antitumor immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.024

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.024

Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.024

Ascitic interleukin-12 is an independent prognostic factor in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.024

Interleukin 12 is associated with reduced relapse without increased incidence of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.024

10.1016/J.YGYNO.2010.05.024

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20603238%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference